Related Experiment Video
Updated: May 22, 2026

An Aptamer-based Sensor for Unchelated Gadolinium(III)
Published on: January 9, 2017
Graphene oxide based fluorescent aptasensor for adenosine deaminase detection using adenosine as the substrate
Xiao-Jing Xing1, Xue-Guo Liu, Yue-He
1Key Laboratory of Analytical Chemistry for Biology and Medicine (Ministry of Education), College of Chemistry and Molecular Sciences, Research Center for Nanobiology and Nanomedicine (MOE 985 Innovative Platform), Wuhan Institute of Biotechnology, and State Key Laboratory of Virology, Wuhan University, Wuhan 430072, China.
We developed a novel graphene oxide (GO)-based fluorescent aptasensor for detecting adenosine deaminase (ADA) activity and inhibition. This sensitive sensor offers a simple, cost-effective platform for ADA detection and drug development.
Area of Science:
- Biochemistry
- Materials Science
- Analytical Chemistry
Background:
- Adenosine deaminase (ADA) plays a crucial role in immune function and is implicated in various diseases.
- Accurate and sensitive detection of ADA activity is essential for disease diagnosis and drug development.
- Existing methods for ADA detection can be complex and lack sensitivity.
Purpose of the Study:
- To develop a novel, highly sensitive, and selective fluorescent aptasensor for detecting adenosine deaminase (ADA) activity and inhibition.
- To utilize graphene oxide (GO) and an adenosine (AD)-specific aptamer for a cost-effective and simple sensing platform.
- To validate the sensor's performance in buffer and human serum samples and assess its potential for drug screening.
Main Methods:
- A fluorescent aptasensor was constructed using a dye-labeled AD-specific aptamer and graphene oxide (GO).
- The sensor leverages the fluorescence quenching effect of GO on the aptamer, which is recovered by AD.
- ADA activity is quantified by the fluorescence quenching resulting from ADA's conversion of AD to inosine, which has no aptamer affinity.
Main Results:
- The aptasensor demonstrated high sensitivity and selectivity for ADA activity detection with a low detection limit of 0.0129 U/mL.
- A strong linear correlation (R=0.9922) was observed when testing human serum samples with varying ADA concentrations.
- The sensor successfully investigated the inhibitory effects of erythro-9-(2-hydroxy-3-nonyl) adenine on ADA activity.
Conclusions:
- The developed GO-based fluorescence aptasensor provides a simple, cost-effective, and sensitive method for ADA activity and inhibitor detection.
- This platform shows significant potential for the diagnosis of ADA-related diseases and facilitates drug development.
- The aptasensor offers a promising tool for biochemical analysis and biomedical applications.

